ABCL
AbCellera Biologics Inc.Company with tickers: ABCL
CIK
1703057
CUSIP
00288U106
Shares Outstanding
305,375,393
Website
https://www.abcellera.com
Investor Relations
https://investors.abcellera.com/overview/default.aspx
13F Activity (30d)
3 filings
2 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Victor Sandor | director | Appointed | 2026-06-05 |